Indian Institute of Technology (IIT) Roorkee researchers have identified a new potential treatment for Chinkungunya, a mosquito-borne viral disease.The researchers indicate that Efavirenz, a widely used HIV drug, has shown potential in reducing chikungunya virus replication in both laboratory tests and in mice models.The outcome is a part of the study conducted by the IIT Roorkee supported by the Indian Council of Medical Research (ICMR). This explored Efavirenz's effects on the Sindbis virus, which is genetically related to the Chikungunya virus. ...